glp-1 weight loss drug marketplace florida changes 2025 drugs, like Ozempic and Wegovy, are changing lives on Long Island — but at a crushing cost for some The GLP-1 Access Gap: Mapping

The rise in diet-related diseases has changed how US consumers view food, with many Americans becoming more conscious of what theyre putting in their bodies and has led to an explosive growth in usage of GLP-1 agonist drugs like Ozempic, Wegovy and Mounjaro, with projections putting the number of users between 10 to 70 million by 2028

Working with a knowledgeable healthcare professional, like a Midi clinician, can help you find a safe, appropriate planeven while new medications are still in development

10.1136/gutjnl-2016-312431 43

doi: 10.3389/fnins.2024.1342944

That makes it cheaper to manufacture and avoids some of the drug interaction concerns

I've been using Prezent AI lately, and I wanted to show you how it works